It was posited that the initial host response to Staphylococcus aureus is a contributing factor in the pathogenesis of acute pneumonia. Having previously observed that T cells play a negative role in the pathogenesis of acute pneumonia to S. aureus the contribution of the CD80/CD86 pathway in pathogenesis was investigated. Mice lacking CD80 and CD86 had significantly improved survival in a mouse model of acute S. aureus pneumonia. This was accompanied by significant reductions in several proinflammatory cytokines, including TNF, MIP-2, IL-1β, IL-17 and IL-6, as well as increased numbers of viable alveolar macrophages. Early during infection reductions in cytokine production were evident and cytokine production in response to S. aureus in bone marrow derived macrophages showed decreases in TNF, KC, IL-1α and GM-CSF. Our data suggest that CD80/CD86 signaling plays a significant role in the initial inflammatory response to S. aureus in the airway and could be a potential acute target to reduce the initial inflammatory insult.
Introduction
S. aureus and in particular methicillin resistant S. aureus (MRSA) is a major problem not only in the hospital setting but in the community, causing significant morbidity, mortality and economic burden [1, 2] . In contrast to hospital-acquired strains, community-acquired strains of S. aureus infect otherwise healthy individuals [3] . The MRSA strain USA300 is the dominant clone and epidemic in the United States [4, 5] . Pneumonias that result from USA300 infection are especially severe and involve significant loss of alveolar architecture, leukocyte infiltration and consolidation of the lung parenchyma [6] . While much has been learned in regards to the cell types important in the response to this pathogen in the airway, many of the signaling pathways that contribute to its pathogenesis remain undefined.
Activation of T cells occurs through interaction of major histocompatibility complex (MHC) presented peptides that interact with the T cell receptor complex, leading to the initiation of various signaling cascades. This signaling complex is also augmented through various coreceptors and their respective ligands. The T cell co-receptor CD28, interacts with CD80 (B7-1) and CD86 (B7-2) that are expressed on activated antigen presenting cells in response to pathogens, which leads to induction of several signaling pathways, such as those controlled by NF-κB, MAPK, PI3K and AKT [7, 8] The laboratory recently identified that T cells contributed to the pathogenesis of S. aureus in a murine model of pneumonia [9] . Mice deficient in T cells had improved outcomes to S. aureus infection and reductions in proinflammatory cytokine production. This is also consistent with our humanized mouse study whereby NOD scid Il2rγ (NSG) mice also had improved outcomes to S. aureus respiratory infection compared to the standard C57BL/6J mouse model [10] . It has also been shown in models of sepsis and skin infection that T cells are associated with the pathogenesis of S. aureus [11] [12] [13] .
Here evidence that expression of CD80 and CD86 contributes significantly to the proinflammatory response in the airway in response to S. aureus is provided. Mice deficient in CD80 and CD86 had significant reductions in several proinflammatory cytokines and have significantly improved rates of survival in a murine model of pneumonia. This requirement of CD80 and CD86 in the proinflammatory response to S. aureus was evident early in infection and in vitro using bone marrow derived macrophages. This works lends support to the hypothesis that much of the morbidity and mortality associated with S. aureus pneumonia is the result of excessive cytokine production.
Materials and methods

Animal studies
C57BL/6J and Cd80Cd86
−/− mice were purchased from Jackson
Laboratories. Mice were infected with Staphylococcus aureus MRSA strain USA300 FPR3757 [5] that was grown in LB broth to mid exponential phase (OD 600 nm 1.0) at 37°C prior to suspension in PBS. Mice were anesthetized with ketamine and xylazine before intranasal administration of 4 × 10 7 cfu for acute or 1 × 10 8 cfu for mortality studies in 50 μl volumes. Bronchoalveolar lavage fluid (BALF) and homogenized lung tissue was used to enumerate bacteria on selective chromogenic media (Chromagar). Clarified BALF fluid was used to quantitate cytokine levels by multiplex technology (Eve Technologies).
Temperatures were measured using a TW2 infrared thermometer (Thermoworks). Animal work in this study was carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory animals of the National Institutes of Health, the Animal Welfare Act, and U.S. federal law. Protocols were approved by the Animal Care and Use Committee of Columbia University.
Flow cytometry
Cells in BALF were stained with the following fluorescently labeled antibodies: MARCO-FITC (MCA1849F; Biorad), CD11c-BV605 (N418), CD86-BV421 (GL-1), CD103-BV510 (M290; BD Biosciences), CD11b-AF594 (M1/70), Ly6G-PerCP Cy5.5 (1A8), CD206-BV650 (C086C2), Siglec-F-AF647 (E50-2440; BD Biosciences), CD45-AF700 (30-F11), MHCII-APC-Cy7 (M5/114.15.2), BUV395 (Life Technologies), CD200R-PE (123,908), Ly6C-PE-Texas Red (AL-2; BD Biosciences) and NK1.1-BV650 (PK136). Viability was assessed using BUV395 live/dead dye (Life Technologies). Antibodies were purchased from Biolegend unless otherwise stated. Cells in the airway were classified as follows [14] 
Cell culture
Macrophages were generated by extracting bone marrow from mouse tibias and femurs, and differentiated using 20 ng/ml of M-CSF (Peprotech) in RPMI 1640 medium with 10% heat inactivated fetal bovine serum and penicillin and streptomycin for seven days. Media was changed to no antibiotics 2 h prior to infection with S. aureus at an MOI of 10 for 24 h before supernatants were collected for multiplex analysis (Eve Technologies).
Statistics
Animal data were assessed using a nonparametric Mann-Whitney test. Mortality data was assessed using a Fishers exact test. In vitro data was assessed using a parametric test. Statistics were performed with Prism software (GraphPad, La Jolla LA USA).
Results
CD80/CD86 contributes to pathogenesis of S. aureus pneumonia
Having previously identified T cells as being a major contributor to the pathogenesis of S. aureus pneumonia [9] the role of CD80/CD86 signaling in infection was investigated. In a model of S. aureus pneumonia, mice missing CD80/CD86 had significantly improved survival. On day 7 post-infection 87.5% of Cd80Cd86 −/− mice had survived compared to 21.4% of WT mice ( Fig. 1A ; P < .01). When the mice were given a lower inoculum to examine the role of CD80/CD86 in the context of non-lethal acute pneumonia no differences in bacterial burden were observed (Fig. 1B) . Bacterial counts in both the bronchoalveolar lavage fluid (BALF) and lung homogenate were not different between the WT and Cd80Cd86 −/− mice (Fig. 1B) . Consistent with the improved outcome in the lethal pneumonia model the temperatures of Cd80Cd86 −/− infected mice were improved compared to similarly infected WT mice (Fig. 1B) . Temperatures in Cd80Cd86 −/− infected mice were on average two degrees higher (P < .01) than WT infected mice. These data show a role for CD80/CD86 in the pathogenesis of S. aureus pneumonia independent of bacterial clearance.
Alveolar macrophages are increased in the absence of CD80/CD86
To better understand the improved outcome of mice lacking CD80/ CD86 multicolor flow cytometry was performed on immune cell populations in the BALF. A preservation of alveolar macrophage cell numbers was observed in addition to CD103 positive dendritic cells in Cd80Cd86 −/− mice compared to WT mice ( Fig. 2A) . Alveolar macrophages have been shown to be important in protection against S. aureus [15] so the 2.6-fold increase (P < .001) has important consequences for pathogenesis. Neutrophils are also important in the clearance of S. aureus but excessive numbers can contribute to inflammation. It was Cytokine 107 (2018) [130] [131] [132] [133] [134] [135] [136] observed that Cd80Cd86 −/− mice had 30% less (P < .05) neutrophils in BALF compared to WT infected mice ( Fig. 2A) . In addition to the difference in alveolar macrophage numbers an overall improvement in their viability was also observed. Alveolar macrophages from Cd80Cd86 −/− infected mice had a mean viability of 93% compared to 86% (P < .0001) in WT infected mice (Fig. 2B) . The scavenger receptor MARCO [16, 17] , was expressed at a level 24% (P < .001) greater on alveolar macrophages from Cd80Cd86 −/− infected compared to WT infected mice (Fig. 2B ). Given this improvement in macrophage numbers it would be expected that this may influence bacterial clearance. As a clearance phenotype was not observed, but a protection against mortality phenotype was observed, the host immune response to S. aureus in WT and Cd80Cd86 −/− mice was further investigated.
3.3.
Signaling from CD80/CD86 contributes significantly to the proinflammatory response to S. aureus in the airway
To gain a better understanding of the improved phenotype observed in Cd80Cd86 −/− mice cytokine levels were quantified in the BALF from control and infected, WT and Cd80Cd86 −/− mice (Fig. 3) . A significant reduction in several proinflammatory cytokines was noted, even in the absence of changes to bacterial counts. This included the major cytokines TNF (56% reduction; P < .001) and IL-6 (44% reduction; P < .05), as well as the neutrophil chemokine KC (78% reduction; P < .05) (Fig. 3) , consistent with our reduced neutrophil numbers (Fig. 2) . IL-17 signaling has been shown to be important in the clearance of extracellular pathogens including S. aureus [18] . In the absence of any changes in bacterial numbers levels of IL-17 were reduced by 79% (P < .0001) in S. aureus infected Cd80Cd86 −/− mice compared to WT infected mice (Fig. 3) . The proinflammatory cytokine IL-1β is a readout for the inflammasome, however, in the airway overproduction of IL-1β can contribute to immunopathology [19] . Levels of IL-1β were reduced by 63% (P < .01) in Cd80Cd86 −/− infected mice compared to WT infected mice (Fig. 3) . Reductions in several other cytokines were also observed: G-CSF, MIP-2, MIP-1β, MIP-1α, M-CSF, MCP-1, LIF, IL-1α, IL-12p40, IL-12p70, IL-15, IL-10, IL-7, IL-13 and IL-3 (Fig. 3) . Changes in cytokine levels were not evident with: eoxtaxin, GM-CSF, IL-2, IL-5, IL-9, CXCL9, CXCL10, RANTES and VEGF (data not shown). These data suggest that CD80/CD86 signaling contributes significantly to the production of proinflammatory cytokines in response to S. aureus in the airway.
Reduced cytokine production in the absence of CD80/CD86 is evident early during infection
To determine if the influence of CD80/CD86 signaling was evident early during infection, WT and Cd80Cd86 −/− mice were infected with S. aureus USA300 for four hours. Consistent with the data from animals 
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Cytokine 107 (2018) [130] [131] [132] [133] [134] [135] [136] infected for 24 h, significant differences in the bacterial counts from the BALF or lung homogenate were not observed (Fig. 4A) . In contrast to the 24 h data (Fig. 1B) , a difference in the body temperature of WT and Cd80Cd86 −/− mice infected with S. aureus was noted (Fig. 4A) . This early time point may be too soon to detect a difference in body temperature. At this early time point a 2.3-fold increase was observed (P < .05) in neutrophil numbers of Cd80Cd86 −/− mice infected with S. aureus compared to similarly infected WT animals (Fig. 4B) . Analysis of the cytokine response in BALF did indicate some early changes (Fig. 4C) . TNF levels were 13% (P < .05) less in Cd80Cd86 −/− infected mice, MIP-2 was reduced by 20% (P < .01), RANTES by 12% (P < .05) and IL-15 by 40% (P < .05). These early changes in cytokine responses indicate that resident cells such as macrophages have a reduced cytokine response.
Macrophages from CD80/CD86 deficient mice have reduced cytokine production
To examine any potential macrophage signaling alternations caused by a lack of CD80/CD86 in response to S. aureus, bone marrow from WT and Cd80Cd86 −/− mice was isolated and differentiated into macrophages. The bone marrow macrophages were then stimulated with S. aureus USA300 for 24 h prior to collection of supernatants for cytokine analysis. Multiple cytokines were observed to be reduced in the absence of CD80/CD86 (Fig. 5) . The neutrophil chemokine KC/CXCL1 was reduced by 48% (P < .001), IL-α was decreased 63% (P < .01), TNF by 75% (P < .05) and GM-CSF by 57% (P < .05). These data indicate that in the absence of CD80/CD86 the proinflammatory capacity of macrophages is reduced and likely contributes to the cytokine phenotype in vivo.
Discussion
It is shown here that the immune response can be a contributing factor to the pathogenesis of infection. T cells are known to contribute to the pathogenesis of S. aureus infection in the lung [9] and it is shown here that mice missing CD80/CD86 also demonstrate improved outcomes. Mice lacking CD80/86 were significantly protected of S. aureus intranasally for 24 h. Cytokines were quantified from BALF. Data is from four independent experiments. Graphs display means with standard error. n = 3-PBS/uninfected and 14 for infected animals. **** P < .0001, *** P < .001, ** P < .01 and * P < .05 compared to WT infected.
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against mortality with S. aureus and exhibited significant decreases in proinflammatory cytokine production. In many cases excessive inflammation or an increased immune response can be detrimental to the host, our data with S. aureus being no exception. Conditions whereby individuals have enhanced activation of the interferon signaling pathway, interferonopathies, suffer from several inflammatory based symptoms [20] . Sufferers of cystic fibrosis are also afflicted with chronic inflammation, in part due to dysregulation of their immune response and an incapacity to resolve infections with Pseudomonas aeruginosa [21] . S. aureus possesses many virulence factors and surface proteins to induce a robust immune response, including various superantigen and superantigen-like proteins [22, 23] in addition to cell wall components.
Typically, the immune response observed to S. aureus in the airway is commensurate with the bacterial load present. In this study significant alternations, reductions, in cytokine production were observed in the absence of changes in bacterial counts in the airway or lung tissue. These data indicate that the reductions in cytokine production were a direct result of the absence of CD80/CD86. Our mortality phenotype is likely due to excessive cytokine production or cytokine storm in the absence of alterations in bacterial burden. Consistent with an absence of CD80/CD86 signaling causing reduced cytokine production, bone marrow macrophages from CD80/CD86 deficient mice were also observed to induce lower cytokine levels in response to S. aureus compared to WT stimulated macrophages.
Inactivation of CD80/CD86 has been observed to improve the outcomes in other models of microbial pathogenesis. In a model of cecal ligation and puncture, mice lacking CD80/CD86 also had reduced mortality and decreased proinflammatory cytokine production [24, 25] . Models of Leishmania and acute parasitemia also saw improvements in outcome [26, 27] , as did inhibition of T cells in the context of pulmonary Streptococcus pneumoniae infection [28] . This is in contrast to Trypanosoma cruzi, whereby in the absence of CD80/ CD86, cytotoxic T cells were impaired that led to exacerbated infection [29] . One difference about the T. cruzi study compared to the current study is that it was a chronic infection model. Our data is supportive that removal or reduction in the early inflammatory signaling of S. aureus in an acute model leads to a reduction in morbidity and mortality.
Through these studies further evidence is provided that the initial acute response to S. aureus in the airway leads to an excessive and detrimental level of cytokine production. This proinflammatory response is directed by many resident cells in the airway and here evidence that expression of CD80/CD86 is a significant contributor to this response is provided. Given that the initial host response to S. aureus in the airway can contribute to pathogenesis, acute therapies to limit this inflammation may prove useful in reducing morbidity and mortality to this important pathogen. 
